Clinical Trial Update: A Global Study of the PETAL Consortium

View source ↗

Summary

A global PETAL consortium trial is currently recruiting to study T-cell and NK-cell neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Natural Killer Cell Neoplasms
• T-cell Neoplasms

Snippet

Sponsor: Massachusetts General Hospital | Conditions: T-Cell and NK-Cell Neoplasm | Status: RECRUITING